Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma

International Journal of Cancer

Volumn 89, Issue 4, 2000, Pages 350-355

  Tannapfel, Andrea ^a   Grund, Dorothee ^a   Katalinic, Alexander ^b   Uhlmann, Dirk ^a   Köckerling, Ferdinand ^c   Haugwitz, Ulrike ^a   Wasner, Mark ^a   Hauss, Johann ^a   Engeland, Kurt ^a   Wittekind, Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Clinic of Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P27;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034691586     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3     Document Type: Article

References (30)

1. Kip1 expression and progression of human esophageal squamous cell carcinoma. Int. J. Cancer, 79, 439-443 (1998).
2. Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res., 59, 684-688 (1999).
3. Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J. nat. Cancer Inst., 90, 916-920 (1998).
4. ESPOSITO, V., BALDI, A., DE LUCA, A., GROGER, A.M., LODA, M., GIORDANO, G.G., CAPUTI, M., BALDI, F., PAGANO, M., and GIORDANO, A., Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57, 3381-3385 (1997).
5. Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396, 177-180 (1998).
6. Kip1 and degree of malignancy in human breast and colorectal cancers. Proc. nat. Acad. Sci. (Wash.), 94, 6380-6385 (1997).
7. FUJIEDA, S., INUZUKA, M., TANAKA, N., SUNAGA, H., FAN, G.K., ITO, T., SUGIMOTO, C., TSUZUKI, H., and SAITO, H., Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int. J. Cancer, 84, 315-320 (1999).
8. GLAISE, D., ILYIN, G.P., LOYER, P., CARIOU, S., BILODEAU, M., LUCAS, J., PUISIEUX, A., OZTURK, M., and GUGUEN-GUILLOUZO, C., Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines. Cell Growth Differentiation, 9, 165-176 (1998).
9. Kip1 accumulation during the cell cycle. Science, 271, 1861-1864 (1996).
10. ISHAK, T. (ed.), Histological typing of tumours of the liver, Springer-Verlag, New York (1994).
11. ITO, Y., and 14 OTHERS, Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology, 30, 90-99 (1999).
12. KAWAMATA, N., and 12 OTHERS, Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269 (1995).
13. LADHA, M.H., LEE, K.Y., UPTON, T.M., REED, M.F., and EWEN, M.E., Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. cell. Biol., 18, 6605-6615 (1998).
14. Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Amer. J. Pathol., 154, 313-323 (1999).
15. LODA, M., CUKOR, B., TAM, S.W., LAVIN, P., FIORENTINO, M., DRAETTA, G.F., JESSUP, J.M., and PAGANO, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature (Med.), 3, 231-234 (1997).
16. MORI, M., MIMORI, K., SHIRAISHI, T., TANAKA, S., UEO, H., SUGIMACHI, K., and AKIYOSHI, T., p27 expression and gastric carcinoma. Nature (Med.), 3, 593 (1997).
17. NURSE, P., The Josef Steiner Lecture. CDKs and cell-cycle control in fission yeast: relevance to other eukaryotes and cancer. Int. J. Cancer, 71, 707-708 (1997).
18. Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer, 85, 1711-1718 (1999).
19. QIN, L.F., NG, I.O., FAN, S.T., and NG, M., p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int. J. Cancer, 79, 424-428 (1998).
20. SANTONI-RUGIU, E., JENSEN, M.R., FACTOR, V.M., and THORGEIRSSON, S.S., Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta 1 signaling disruption. Amer. J. Pathol., 154, 1693-1700 (1999).
21. SINGH, S.P., LIPMAN, J., GOLDMAN, H., ELLIS, F.H., JR., AIZENMAN, L., CANGI, M.G., SIGNORETTI, S., CHIAUR, D.S., PAGANO, M., and LODA, M., Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res., 58, 1730-1735 (1998).
22. SOBIN, L.H., and WITTEKIND, CH. (eds.), TNM classification of malignant tumors, 5th ed., Wiley-Liss, New York (1997).
23. SPIRIN, K.S., SIMPSON, J.F., TAKEUCHI, S., KAWAMATA, N., MILLER, C.W., and KOEFFLER, H.P., p27/Kip1 mutation found in breast cancer. Cancer Res., 56, 2400-2404 (1996).
24. TAN, P., CADY, B., WANNER, M., WORLAND, P., CUKOR, B., MAGI-GALLUZZI, C., LAVIN, P., DRAETTA, G., PAGANO, M., and LODA, M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57, 1259-1263 (1997).
25. TANNAPFEL, A., ENGELAND, K., WEINANS, L., KATALINIC, A., HAUSS, J., MOESSNER, J., and WITTEKIND, CH., Expression of p73, a novel protein related to the p53 tumour suppressor, and apoptosis in cholangiocellular carcinoma of the liver. Brit. J. Cancer, 80, 1069-1074 (1999).
26. TANNAPFEL, A., WASNER, M., KRAUSE, K., GEISSLER, F., KATALINIC, A., HAUSS, J., MOESSNER, J., ENGELAND, K., and WITTEKIND, CH., Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J. nat. Cancer, Inst., 91, 154-158 (1999).
27. THOMAS, G.V., SZIGETI, K., MURPHY, M., DRAETTA, G., PAGANO, M., and LODA, M., Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Amer. J. Path., 153, 681-687 (1998).
28. TSIHLIAS, J., KAPUSTA, L., and SLINGERLAND, J., The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Ann. Rev. Med., 50, 401-423 (1999).
29. Kip1 over-expression causes apoptotic death of mammalian cells. Oncogene, 15, 2991-2997 (1997).
30. WITTEKIND, CH. Hepatocellular carcinoma. In: P. Hermanek, M.K. Gospodarowicz, D.E. Henson, R.V.P. Hutter, and L.H. Sobin (eds.), Prognostic factors in cancer, pp. 88-94, Springer-Verlag, New York (1995).